A complex interaction of signalling events, including the Wnt pathway, regulates sprouting of blood vessels from pre-existing vasculature during angiogenesis. Here we show that two distinct mutations in the (uro)chordate-specific gumby (also called Fam105b) gene cause an embryonic angiogenic phenotype in gumby mice. Gumby interacts with disheveled 2 (DVL2), is expressed in canonical Wnt-responsive endothelial cells and encodes an ovarian tumour domain class of deubiquitinase that specifically cleaves linear ubiquitin linkages. A crystal structure of gumby in complex with linear diubiquitin reveals how the identified mutations adversely affect substrate binding and catalytic function in line with the severity of their angiogenic phenotypes. Gumby interacts with HOIP (also called RNF31), a key component of the linear ubiquitin assembly complex, and decreases linear ubiquitination and activation of NF-kB-dependent transcription. This work provides support for the biological importance of linear (de)ubiquitination in angiogenesis, craniofacial and neural development and in modulating Wnt signalling.
A complex interaction of signalling events, including the Wnt pathway, regulates sprouting of blood vessels from pre-existing vasculature during angiogenesis. Here we show that two distinct mutations in the (uro)chordate-specific gumby (also called Fam105b) gene cause an embryonic angiogenic phenotype in gumby mice. Gumby interacts with disheveled 2 (DVL2), is expressed in canonical Wnt-responsive endothelial cells and encodes an ovarian tumour domain class of deubiquitinase that specifically cleaves linear ubiquitin linkages. A crystal structure of gumby in complex with linear diubiquitin reveals how the identified mutations adversely affect substrate binding and catalytic function in line with the severity of their angiogenic phenotypes. Gumby interacts with HOIP (also called RNF31), a key component of the linear ubiquitin assembly complex, and decreases linear ubiquitination and activation of NF-kB-dependent transcription. This work provides support for the biological importance of linear (de)ubiquitination in angiogenesis, craniofacial and neural development and in modulating Wnt signalling.
During angiogenesis, new blood vessels sprout from pre-existing vasculature to form a microcapillary network and become uniquely adapted to the physiology and function of the organs that they infiltrate (reviewed in ref. 1) . Several well-characterized molecular pathways direct vascular patterning, but contributions of Wnt pathways are just emerging. Wnt signalling pathways control a broad spectrum of events, including cell-fate specification, proliferation and migration (reviewed in ref. 2) , and are grouped into the canonical, b-catenindependent and non-canonical pathways. Both canonical and noncanonical Wnt pathways influence angiogenesis (reviewed in refs 3, 4) . Canonical Wnt signalling is required for angiogenesis in the CNS 5, 6 , whereas non-canonical Wnt signalling has been implicated in global early embryonic angiogenesis 7 . The events that occur in Wnt-responsive cells depend, in part, on dishevelled and its associated proteins to transmit stimuli to the appropriate pathway(s) (reviewed in ref. 8) .
Protein modifications, such as ubiquitination, offer a rapid mechanism by which cells integrate inputs from signalling pathways. Ubiquitin is an evolutionarily conserved 76-amino-acid protein used to label and alter the fate of cellular proteins. During protein ubiquitination, a covalent bond is generated most commonly between the most carboxy-terminal amino acid residue, a glycine, and a lysine in the modified protein. Ubiquitin itself contains seven lysine residues that can undergo ubiquitination to form polyubiquitin oligomers (chains). These chains serve to direct protein localization, stability and activity. The linear ubiquitin assembly complex (LUBAC), comprised of HOIL-1/1l, HOIP (also called RNF31) and sharpin proteins, mediates formation of an atypical ubiquitin chain topology 9 involving the linear linkage of the C terminus of glycine 76 in one ubiquitin protomer to the free amino terminus of methionine 1 in a second protomer (reviewed in refs [10] [11] [12] . So far, linear ubiquitination has been shown to regulate NF-kB-dependent inflammation and adaptive immunity [13] [14] [15] [16] . Deubiquitination, the selective removal of ubiquitins, is equally important and is performed by members of five distinct deubiquitinase (DUB) families, one of which is the ovarian tumour (OTU) domain containing protease family 17 . Currently, no DUB has been shown to cleave linear ubiquitin chains exclusively.
Here, our studies of the recessive, embryonically lethal gumby mouse mutant and its angiogenic phenotype have led to the identification of the affected (uro)chordate-specific gene, Fam105b (which we call gumby (Gum)). We show that gumby encodes a linear ubiquitinspecific DUB that structurally belongs to the OTU family. Gumby can associate with LUBAC and counteract known LUBAC functions. We identify a role for the gumby-LUBAC axis in regulating canonical Wnt signalling. Our findings highlight the importance of linear (de)ubiquitination in angiogenesis, craniofacial and neuronal development, and Wnt signalling.
The gumby mutation causes embryonic angiogenic deficits gumby/gumby mice were identified based on abnormal sprouting of the facial nerve at embryonic day (E)10.5 18 , appear normal before E11.5, but die between E12.5-E14. Because shared molecular mechanisms can guide axons and blood-vessel branching, we examined vascular development in E10.0-11.0 1/1, gumby/1 and gumby/ gumby embryos by whole-mount immunohistochemistry with platelet endothelial cell adhesion molecule-1 (PECAM-1) antibody (Supplementary Fig. 1 ). The major structures of the vascular system appeared similar in controls and mutants. However, branching vascular networks in the head and trunk were improperly organized and less complex in gumby homozygotes. In the medial region of the embryonic head, several large-diameter cranial vessels branch to form a hierarchical vascular network ( Supplementary Fig. 1a, b ). In gumby/gumby embryos, large cranial vessels were dilated, branching reduced and endothelial cells accumulated at branch points ( Supplementary Fig. 1e , f and Fig. 1i ). Normally, a 'capillary' network, the perineural vascular plexus (PNVP), forms in the trunk between intersomitic vessels and extends into the neurectoderm ( Supplementary Fig. 1c, d) 19 . In gumby/ gumby embryos, fewer and less elaborate vessel extensions formed between the somites and the PNVP ( Supplementary Fig. 1g , h and Fig. 1l ).
Gum W96R causes the gumby phenotypes
Meiotic mapping of 154 progeny from gumby/1 intercrosses refined the critical interval to 1.7 megabases (Mb) between D15Mit18 (26.7 Mb) and single nucleotide polymorphism (SNP) rs13482490 (28.4 Mb) on mouse chromosome 15 (Ensembl assembly v35) (Supplementary Fig. 2 ). Sequencing genes within this interval identified a T-to-A transversion (T285A) in the third exon of the Fam105b (also called BC087945) gene, which substitutes tryptophan at position 96 to arginine, and is referred to as Gum W96R (Fig. 1b ). Tryptophan 96 is conserved in all known orthologues ( Fig. 1d ). Whereas Ciona intestinalis and Ciona savigyni genomes each carry a copy, related genes are absent in non-chordates. We hereafter refer to Fam105b as the gumby (Gum) gene.
To test whether this is the gumby causative gene, we performed rescue experiments with bacterial artificial chromosome (BAC) bMQ-396D that spans the gumby gene and ,60 kilobases (kb) of its flanking region ( Fig. 1a , e-o and Supplementary Fig. 3 ). One founder BAC transgenic line rescued the lethality ( Fig. 1 g, o) and vascular deficits ( Fig. 1j , m) of gumby/gumby mice. Thus, this mutation causes the gumby phenotype, and we refer to this gumby allele as Gum W96R .
Identification and analysis of gumby allele Gum D336E
We identified mice carrying another allele of gumby, Gum D336E , by screening a bank of cryopreserved sperm and genomic DNA from over 6,000 G1 male progeny from N-ethyl-N-nitrosourea mutagenized G0 males (http://www.brc.riken.jp/lab/gsc/mouse/index.html) 20 . In the Gum D336E allele, a T-to-A transversion in exon 7 changes conserved aspartate 336 to glutamate ( Fig. 1c ). Both Gum W96R and Gum D336E homozygotes show reduced branchial arches and embryonic lethality after E12.5 (data not shown). Using anti-PECAM-1 whole-mount immunofluorescence, we quantified the relative deficits in the cranial vasculature of Gum D336E and Gum W96R homozygotes at E10.5 ( Fig. 2a-f ). We found decreased numbers of secondary and tertiary vessels branching off the internal carotid artery (ICA) in Gum W96R (Fig. 2c , g) and Gum D336E ( Fig. 2e , g) homozygotes relative to 1/1 littermates ( Fig. 2a , g). We examined vessel dilation by measuring the diameter of the ICA before its migration to the posterior head region ( Fig. 2b , d, f, h) and secondary branch dilation by measuring the diameter of the first branch off the ICA ( Fig. 2b , d, f, i). Gum W96R homozygotes had larger dilated ICAs ( Fig. 2h ) and secondary branches ( Fig. 2i ) compared to 1/1 and Gum D336E homozygotes. Immunoblot and immunofluorescence experiments indicate that the Gum W96R and Gum D336E mutations do not detectably compromise gumby protein level or cytoplasmic localization ( Supplementary Fig. 4 ). These findings further support an angiogenic requirement for gumby and predict that the Gum W96R mutation affects protein function more severely than Gum D336E .
Gumby messenger RNA is transcribed in the developing vasculature and other regions affected in mutants, including branchial arches and neural crest cells ( Fig. 2j-l and Supplementary Fig. 5 ). The walls of blood vessels are composed of endothelial cells, which line the luminal vessel surface, and perivascular cells, which encircle the outside of the vascular endothelium 21 . In immunofluorescence experiments on E10.5-E11.5 embryonic sections with an anti-gumby antibody (Supplementary Fig. 6 ), gumby protein co-localized with the endothelialspecific marker PECAM-1, but not perivascular markers smooth muscle actin and desmin ( Fig. 2m -p and data not shown). Gumby protein is enriched in a subset of endothelial cells. Gumby-enriched endothelial cells were present throughout intersomitic vessels (ISVs) and, in the PVNP and cranial vasculature, often located near possible leading regions of vessels (arrows, Fig. 2n , p) or at 'vascular buds' (arrowheads, Fig. 2n , p).
Gumby is a DUB that cleaves linear ubiquitin chains Gumby (FAM105B) was identified in the NCBI database as a putative member of the OTU-fold DUBs, a prediction that we confirmed by 
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X-ray crystallographic analysis to 1.6 Å resolution (Supplementary Table 1 ). With 14.9% sequence identity ( Supplementary Fig. 7 ) and a superimposable catalytic triad (Cys 129, His 339 and Asn 341), gumby most closely resembled the catalytic domain of OTUB1 (root mean squared deviation (r.m.s.d.) 5 2.09 Å ) [22] [23] [24] , a DUB that specifically cleaves K48-linked ubiquitin chains 22, 25 (Fig. 3a ). As such, we examined DUB activity against all eight diubiquitin chain linkages in vitro ( Fig. 3b , right panel). In contrast to OTUB1, gumby displayed selectivity for linear diubiquitin (Fig. 3b left panel). DUB activity was dependent on Cys 129, was not measurable against ubiquitin-AMC, and was insensitive to inhibition by ubiquitin-vinyl sulphone (Supplementary Fig. 8a -c). Unlike OTUB1 (refs 22, 25) , residues preceding the catalytic domain were not required for DUB activity (compare Gum M55 and Gum R79 in Supplementary Fig. 8d ). The gumby mutations Trp96Arg and Asp336Glu mapped to a surface of the OTU-fold 14.1 Å and 11.4 Å , respectively, from the catalytic cysteine ( Fig. 3a) , positions expected to have an impact on catalytic function. In confirmation, kinetic analysis of the W96R mutant revealed ,10,000and 5-fold perturbations in k cat and K m , respectively, whereas the D336E mutant revealed ,50-fold perturbation in k cat (Supplementary Fig. 8d ). These effects on enzymatic function paralleled the relative severity of mutant phenotypes in vivo ( Fig. 2a -i).
We solved the 2.4 Å and 2.8 Å crystal structures of gumby in the presence of free ubiquitin and linear diubiquitin substrate, respectively (Supplementary Table 1 ). Linear diubiquitin engaged an extensive surface (total buried surface area 5 3,267 Å 2 ) on gumby with the active site Cys 129 centrally positioned at the scissile bond linking Gly 76 and Met 1 of distal and proximal ubiquitin moieties ( Fig. 3a ). Monoubiquitin engaged the distal ubiquitin-binding site of gumby similar to the mode observed in the diubiquitin ( Supplementary Fig. 9a ) costructure, but different from modes observed in yeast Otu1, viral OTU and human OTUB5 co-structures, possibly reflecting differences in substrate specificities ( Supplementary Fig. 9b ).
In the diubiquitin complex, distally bound ubiquitin engaged gumby through a combination of hydrophobic and polar interactions burying a large total surface area of 1,771 Å 2 (Fig. 3c, d ). The contact surface on distal ubiquitin was composed of strands b3, b4, loops connecting b1-b2, b3-b4, and the C-terminal tail, whereas the reciprocal surface on gumby was composed of helix a8, loops between b2-a3, a9-a10 and b3-b4 ( Fig. 3c and Supplementary Fig. 7 ). Proximally bound ubiquitin engaged gumby primarily through hydrophilic interaction, burying a total surface area of 1,496 Å 2 . The interaction surface on proximally bound ubiquitin was composed of strands b1, b2, helix a1 and loops between b2-a1 and b3-b4, whereas the reciprocal contact surface on gumby was composed of helices a1, a2, loop regions b2-a3, a9-a10 and b5-b6. A detailed list of contact residues and side-chain interactions between linear diubiquitin and gumby are shown in Fig. 3d and Supplementary Fig. 9c, d .
The prominent position of Trp 96 and Asp 336 in the general vicinity of the active site and on the direct contact surface with diubiquitin substrate allowed rationalization of the differential effects of the Trp96Arg and Asp336Glu gumby mutations. As a generally conserved hydrophobic position in OTU sequences, Trp 96 contributes to enzyme structure in addition to mediating a direct contact with Lys 33 of the proximally bound ubiquitin ( Fig. 3d and Supplementary  Fig. 9d ). Mutation of the partially buried Trp side chain to Arg would perturb both local structure and substrate binding affinity, manifesting in the observed changes to both k cat and K m . Consistent with this inference, mutation of the topologically equivalent hydrophobic position in OTUB1 (Tyr61Arg) abolished all trace of catalytic function ( Supplementary Fig. 8e ), and direct binding experiments showed a ,20-fold loss in substrate affinity for the Trp96Arg gumby mutant ( Supplementary Fig. 8f ). From its highly solvent-exposed position in the apo structure, Asp 336 contributes less to enzyme structure than Trp 96 while forming a direct salt interaction with Lys 29 of the proximal site ubiquitin. Thus, the conservative Asp336Glu mutation would impact less on active site structure than the Trp96Arg mutation while preserving a favourable salt interaction with Lys 29 on ubiquitin, manifesting in the observed smaller change to k cat and no change to K m .
Comparison of gumby with OTUB1 (Protein Data Bank accession 4DDG) 23 allows for a rationalization of its unique substrate specificity and regulation ( Supplementary Fig. 9e ). Despite using equivalent 
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topological surfaces on their OTU folds for substrate engagement (centre of mass positions for distal and proximal ubiquitins differ by only 1.6 and 3.9 Å , whereas angles of rotation differ more greatly by 60u and 135u, respectively), only 2 of 45 total contact residues on gumby, namely Cys 129 and His 339, were conserved in OTUB1. Because both gumby and OTUB1 engage continuous and extensive surfaces spanning both ubiquitin molecules in their respective diubiquitin substrates, centred on the site of cleavage, this would greatly constrain the ability of each enzyme to recognize substrates with alternative linkage topologies, which present vastly different interaction surfaces. Similar to OTUB1, a productive orientation of the catalytic triad is only apparent for gumby bound to diubiquitin substrate. The coupling of catalytic activation with the binding of preferred substrate (Fig. 3e ) would further accentuate specificity by prohibiting cleavage of partially and/or suboptimally engaged substrates.
Gumby interacts with and can counteract LUBAC
We identified the LUBAC component HOIP as a gumby interactor by affinity purification of Flag-tagged gumby and its associated proteins followed by mass spectrometry (AP-MS). Whereas full-length gumby possesses a PDZ binding motif (PBM) and interacts with multiple PDZ-domain-containing proteins when expressed in HEK293 cells (data not shown), a gumby construct containing a mutated PBM consisting of four sequential alanine residues (gumby DPBM ) ( Fig. 4a ) interacted with HOIP ( Fig. 4b and Supplementary Table 2 ). No other LUBAC components were detected, suggesting that the interaction with HOIP may be independent of other delineated LUBAC components. By performing immunoprecipitation coupled to immunoblotting using Flag-gumby expression constructs, we confirmed this interaction and mapped it to the N terminus of gumby. A construct truncated at position 105 (gumby C105X ) sufficed to mediate the interaction, whereas one missing the first N-terminal 54 residues (gumby D54 ) could not interact with HOIP. HOIP interacted with wild-type gumby and gumby C129S proteins equivalently ( Fig. 4c-e ). Thus, gumby interacts through its N terminus with HOIP independently of its PBM or catalytic DUB domain. Next we tested whether gumby could affect linear ubiquitination of proteins in vivo. Co-expressing HOIL and HOIP in HEK293T cells increased the level of linearly ubiquitinated proteins in immunoblot and immunofluorescence experiments using an anti-linear ubiquitin antibody 26 (Fig. 4f-h and Supplementary Fig. 10 ). Co-transfection of Flag-gumby-but not Flag-gumby C129S and Flag-gumby W96R -with HOIL and HOIP decreased overall levels of proteins modified with linear ubiquitin ( Fig. 4f and Supplementary Fig. 10 ). In mice, levels of linearly ubiquitinated proteins were elevated in E10.0 Gum W96R / Gum W96R embryos relative to their 1/1 and heterozygous littermates, as detected by immunoblot analyses using an anti-linear ubiquitin antibody (Fig. 4i ). Thus, the Gum W96R mutation compromises linear deubiquitination in cell culture and animals.
Finally, we examined whether gumby could oppose LUBAC-dependent activation of NF-kB-directed transcription (Fig. 4j, k) . Co-transfecting an NF-kB-dependent reporter construct with gumby or gumby DPBM caused ,100-fold inhibition of LUBAC-dependent activation in HEK293T cells. Gumby C129S , gumby W96R and gumby C105X could not repress this activation to an equivalent level. Neither LUBAC components nor gumby in combination or alone affects AP2-dependent transcription (data not shown), suggesting that these are not effects on general transcription. Whereas gumby interacts with HOIP via its 
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N-terminal region, in these assays, gumby D54 can still antagonize LUBACdependent activation. Thus, in an overexpression system, the ability of gumby to fully offset LUBAC function requires its catalytic activity.
Gumby and LUBAC modulate Wnt signalling
Recovery of gumby as a dishevelled 2 (DVL2) interactor in a yeast twohybrid screen suggested a role for gumby in Wnt signalling 27 . We confirmed the gumby-DVL2 interaction in HEK293T cells by immunoprecipitation of haemagglutinin (HA)-tagged DVL2, which recovered Flagtagged gumby and gumby C129S equivalently and reciprocally (Fig. 5a-c) . Gumby D54 could not interact with DVL2, whereas gumby C105X could. Thus, gumby interacts with DVL2 via its N-terminal region.
Canonical Wnt signalling activates T-cell-specific transcription factor/lymphoid enhancer factor (TCF/LEF) to induce downstream target gene expression 2 . We tested whether gumby might modulate canonical Wnt3a signalling by assaying TCF/LEF-dependent luciferase expression of the TOPFLASH reporter in HEK293T cells ( Fig. 5d-g) . Flag-gumby could enhance luciferase expression in the presence of WNT3A. Flag-gumby W96R or Flag-gumby C129S enhanced WNT3Ainduced TOPFLASH expression to a lesser degree. When we asked whether gumby and LUBAC might have opposing roles in Wnt signalling, we found that co-expressing HA-HOIL and Myc-HOIP together inhibited TOPFLASH expression over tenfold. Addition of Flaggumby or gumby D54 reversed HOIL-HOIP-dependent inhibition, but addition of Flag-gumby C129S or gumby W96R did not. The same trends were seen in the presence of DVL2 ( Fig. 5 f, g) . These data indicate that linear (de)ubiquitination via the gumby-LUBAC axis can modulate canonical Wnt signalling.
To determine whether gumby compromised Wnt response in endothelial cells, we took advantage of canonical Wnt pathway reporter mice (TOPGAL) that carry a transgene with LEF/TCF binding sites directing b-galactosidase (b-gal) expression 28 . In triple Supplementary Table 2 . c-e, Immunoprecipitation coupled to immunoblotting using Flag-gumby expression constructs, HA-HOIL and Myc-HOIP determined that HOIP interacts with wild-type gumby (1), gumby W96R (W), gumby C129S (C), gumby DPBM (P) and gumby C105X (105) 
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immunofluorescence experiments using antibodies against b-gal, gumby and PECAM-1 at signal saturation for b-gal, gumby protein is expressed exclusively in endothelial cells expressing b-gal in E10.5 1/1;TOPGAL/1, Gum W96R /Gum W96R ;TOPGAL/1 and Gum D336E / Gum D336E ;TOPGAL/1 embryos ( Supplementary Fig. 11 ). Gumby/bgal co-localization was also seen in the dorsal root ganglia and telencephalon ( Fig. 5h, k, Supplementary Fig. 11 , and data not shown). To test whether canonical Wnt signalling read-out might be affected in mutant endothelial cells, we analysed relative b-gal levels in ISVs, because, in these, all endothelial cells co-express b-gal and gumby ( Supplementary Fig. 11 ) and their stereotypic organization facilitates comparative analyses. Under conditions where we detect intermediate b-gal signal in PECAM-1-labelled ISVs of E10.5 1/1;TOPGAL/1 embryos, b-gal immunofluorescence was significantly reduced in Gum W96R /Gum W96R ;TOPGAL/1 and Gum D336E /Gum D336E ;TOPGAL/ 1 embryos ( Fig. 5 h-o) . Levels were also reduced in other gumbyexpressing regions, including the dorsal root ganglia and telencephalon (data not shown). We note that Gum W96R and Gum D336E homozygotes show a CNS-specific angiogenic phenotype similar to that reported upon disruption of canonical Wnt signalling 5,6 . Thus, these findings suggest a role for gumby in canonical Wnt signalling during angiogenesis.
Discussion
Here we have shown that loss of the linear DUB activity of gumby compromises angiogenesis and neuronal and craniofacial development. So far, biological roles identified for LUBAC components in the mouse have been milder. Mutations in sharpin lead to chronic proliferative dermatitis 29, 30 . HOIL-1/1l mouse mutants show no overt pathology unless challenged 31 . HOIP mutant phenotypes remain to be reported. Explanations for these observations include the existence of other LUBAC complexes or components, or unappreciated functional redundancy between sharpin and HOIL. Also, in the absence of gumby, constitutive linear ubiquitination of proteins could be more damaging than absence of linear ubiquitination. For instance, in cases where linear ubiquitination is inhibiting Wnt signalling, Wnt signalling could not be (re)activated by deubiquitination. Our work reveals that gumby, via its N terminus, interacts with HOIP and DVL2. In overexpression experiments, the ability of gumby to fully counteract LUBAC function requires its catalytic activity. However, in vivo, at endogenous protein levels, the N-terminal interaction may have important functions-perhaps to regulate activity of the overall complex, guide substrate selection, direct subcellular localization or direct gumby to modulate specific pathways.
In humans, deletions of the gumby-containing interval on chromosome 5p15.2 are associated with mental retardation and craniofacial anomalies observed in patients with cri du chat syndrome (CdCS) [32] [33] [34] .
Although not the only gene deleted, gumby might contribute to some CdCS symptoms via its effects on linear deubiquitination.
In summary, our work has identified gumby as a linear ubiquitinspecific DUB with roles in angiogenesis, other developmental processes and Wnt signalling. This paves the way for future investigations into the identification of gumby substrates, understanding of the roles Flag-axin: Lane: 
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and regulation of the linear deubiquitination-ubiquitination balance and possibly development of antiangiogenic therapies.
METHODS SUMMARY
All mouse husbandry and handling was performed in conformity with the Canadian Council of Animal Care recommendations (AUP 0024a-00H). For all experiments, unless otherwise stated, a minimum of six homozygous mutants of each genotype and six 1/1 littermates were examined. X-ray structure analyses, binding studies using ITC, deubiquitination assays, RNA and protein expression analyses, immunoprecipitations and Wnt reporter expression analyses in vivo and in cell culture were performed by standard methods and are described in detail in Methods.
METHODS
X-ray structure analyses, binding studies using ITC, deubiquitination assays, RNA and protein expression analyses, immunoprecipitations and Wnt reporter expression analyses in vivo and in cell culture were performed by standard methods. Mouse husbandry. All mouse husbandry and handling was performed in conformity with the Canadian Council of Animal Care recommendations (AUP 0024a-00H). For all experiments, unless stated otherwise, a minimum of six gumby (Gum W96R ) and Gum D336E homozygotes and six 1/1 littermates were examined. Both mutations arose and were ultimately maintained on the C57BL6/J background.
For fine-mapping the gumby (Gum W96R ) mutation, heterozygous carriers and homozygous mutants were identified with D15Mit130 and D15Mit111. Recombinant embryos were scored with D15Mit252, D15Mit280, D15Mit18, D15Mit201 from http://www.informatics.jax.org/strains_SNPs.shtml and SNP markers rs3707949 and rs13482490 from http://www.ncbi.nlm.nih.gov/projects/ SNP. Once identified, a tetra-primer ARMS-PCR assay was used to identify the Gum W96R and Gum D336E mutations essentially as described previously 35 .
All primer sequences are listed in Supplementary Table 3 .
Mice transgenic for bMQ-396D3 BAC (Chr.15: 27,544,413-27,629,541 bp) from AB2.2 embryonic stem cell DNA (129S7/SvEvBrd-Hprt b-m2 ) 36 were generated by the Michigan University Transgenic Core into (C57BL/6 X SJL)F 2 females. The breeding strategy to produce Gum W96R /Gum W96R ;BAC transgenic mice is shown in Supplementary Fig. 3 .
To assess canonical Wnt signalling, homozygous TOPGAL mice 37 were crossed with Gum W96R /1 and Gum D336E /1 mice. Gum W96R /1;TOPGAL/1 mice and Gum D336E /1;TOPGAL/1 mice were backcrossed to their respective heterozygous mutant backgrounds to obtain Gum W96R /Gum W96R ;TOPGAL/1 and Gum D336E / Gum D336E ;TOPGAL/1 embryos. Sequencing. Coding sequences of candidate genes were amplified by PCR of exons and flanking introns from genomic DNA or cDNA from gumby/gumby E11.5 embryos. For expression constructs, wild-type gumby coding region was amplified from I.M.A.G.E. clone 4430188 and gumby W96R from Gum W96R / Gum W96R E10.5 embryonic cDNA using the Superscript first-strand synthesis system (Invitrogen). All clones were verified by sequencing. Expression analyses. Northern blot analyses were performed using total RNA purified with Trizol (Invitrogen) at 20 mg per lane and resolved as described previously 38 .
Whole-mount RNA in situ hybridization was performed, as previously described 39 , using gumby cDNA region 459-1,059 bp, corresponding to AA153-352, cloned into SacI/EcoRI sites of pBluescript SKII (Stratagene). Templates for antisense probes were generated by XhoI digestion and transcription with T7 polymerase, and sense probes by ClaI digestion and transcription with T3 polymerase. Anti-gumby polyclonal antibody. Glutathione S-transferase (GST)-tagged gumby protein (gumby-GST) was used to generate anti-gumby antibody in rabbits by the Laboratory Division of Comparative Medicine, University of Toronto. Antibody was purified with Affi-Gel15 coupled to maltose binding protein-tagged gumby fusion protein (MBP-gumby). Vectors used were pGEX-HTa (GE Healthcare) and pMAL-C2 vector (New England Biolabs).
Antibody specificity was tested by diluting in either 5% non-fat instant milk powder/TBST (immunoblot) or 10% normal goat serum/PBST (immunofluorescence) and incubating it with either GST-gumby or GST alone, immobilized to glutathione-Sepharose 4B beads (GE Healthcare). After 1.5 h of rocking at room temperature, beads were spun down, and the supernatant was used as a primary antibody ( Supplementary Fig. 6 ). Immunofluorescence. Cells, embryos and tissues were fixed in 4% paraformaldehyde (Sigma). Embryos and tissues were embedded in Tissue-Tek OCT (Miles laboratories) and sectioned at 16-20 mm. Samples were washed in PBS, blocked in PBST (PBS-0.3% Triton X-100) with 10% NGS for 2.5 h at room temperature, incubated with primary antibodies diluted in PBST-1% NGS overnight at 4 uC, washed in PBS, incubated with fluorescently labelled secondary antibodies for 1 h at room temperature, washed in PBS and mounted with Vectashield Mounting Medium with DAPI (Vector Laboratories). Whole-mount immunohistochemistry with anti-CD31 antibody (1:1,000) was performed as previously described 40 .
Antibodies used were: rabbit anti-mouse gumby (1:500); mouse monoclonal anti-human smooth muscle actin (clone 1A4 DAKO, 1:1,000); monoclonal mouse anti-human desmin (clone D33 DAKO, 1:1,000); mouse anti-Flag M2 (Clone F1804 Sigma, 1:1,000); hamster anti-mouse CD31 (PECAM-1) (Millipore 1398Z, 1:500); chick anti-b-galactosidase (Abcam); anti-linear ubiquitin (Genentech, 1 mg ml 21 ) antibodies. Secondary antibodies were goat anti-rat FITC, donkey anti-chick Cy3, donkey anti-hamster Cy2, donkey anti-rabbit Cy3 (all from Jackson Immunoresearch); donkey anti-mouse AlexaFluor 488, goat anti-mouse AlexaFluor 594, goat anti-rabbit AlexaFluor 488, goat anti-rabbit AlexaFluor 594 (all from Molecular Probes); goat anti-chick Alexa 488, goat anti-hamster Alexa 647 and goat anti-chick Alexa 488 (all from Invitrogen).
Immunofluorescence was visualized using a Nikon D-eclipse C1 confocal microscope system, Leica MZFIII microscope equipped with Qimaging 1300C digital camera or Leica spinning disc confocal microscope and analysed with Adobe Photoshop and Volocity or ImageJ. Anti-b-gal immunofluorescence. Immunofluorescence was performed on matched sections blocked for 1 h with 5% NGS, 5% normal donkey serum (NDS), 1% blocking solution (prepared from a 10% solution in maleate buffer), 20 mM MgCl 2 , 0.3% Tween-20 in PBS. Chick anti-b-galactosidase, Cy3-anti-chicken and Cy2-antihamster were each pre-incubated for 1 h at room temperature with 3 mg mouse embryo powder in 2% NGS, 2% NDS, 1% blocking solution, 20 mM MgCl 2 , 0.3% Tween-20 in PBS, centrifuged at 10,000g for 10 min at 4 uC, then applied to sections at appropriate dilution. Three lots of chick anti-b-gal antibody were tested to identify one optimal preparation. Sections were incubated with anti-b-gal and hamster anti-PECAM-1 antibodies for 14-18 h at 4 uC, washed five times with PBS/0.2% Tween. Secondary antibodies were applied at 1:400 dilutions for 45 min. Sections were washed in PBS three times and mounted as usual. Using serial dilutions ranging from 1:100 to 1:4,000, we determined that immunofluorescent anti-b-gal signal was saturated at 1:200 to 1:500, not detectable at 1:2,000, and present at intermediate levels at 1:1,000 dilution on 1/1;TOPGAL/1 sections.
To establish gumby and b-gal co-localization in endothelial cells within ISVs, we used the 1:500 anti-b-gal dilution, analysed more than three animals per genotype and found complete co-localization in ISVs. For quantification purposes, we counted .100 cells from .10 ISVs per genotype. Gumby and b-gal expression in other embryonic endothelial cells is less uniform. Given the phenotypes we observed in blood vessels within the neural tissue, we focused analyses on these by sampling 394 endothelial cells in 20 transverse sections through an E10.5 1/1;TOPGAL/1 embryo.
We used the 1:1,000 dilution in subsequent quantification experiments. Experiments were performed in parallel on a minimum of six sections from three animals per genotype. Images were collected as 3.5-mm stacks under identically set conditions for all samples. For quantification, at least 15 ISVs located between the fore-and hindlimbs were sampled per genotype. Immunofluorescence was analysed using ImageJ software 41 . PECAM-positive endothelial cells in ISVs were traced as a group and the mean fluorescent intensity of ISVs (that is, of endothelial cells within ISVs) was measured. A Kruskal-Wallis test (k 5 3) based on ranks was performed on the data, as they did not meet the parametric assumptions regarding normality and equivalence of variance. Effect of gumby genotype on anti-b-gal mean fluorescence intensity was highly significant (H 5 43.69; P , 0.0001). Immunoblot analysis. Transfected cells and mouse tissues were lysed in RIPA buffer (1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, in PBS pH 7.4 with protease inhibitor cocktail tablet (Roche)). SDS-polyacrylamide gel electrophoresis was performed with 10-15 mg of total lysate and immunoblot analysis was performed as described. To control for loading, membranes were stripped and probed for tubulin.
Antibodies used were rabbit gumby (1:5,000); mouse tubulin (Clone DM1A Sigma, 1:2000); goat HRP-IgG (anti-rabbit, rat, human or mouse) (Jackson Immunoresearch, 1:10,000); mouse Flag (Sigma M2, 1:1,000); rat HA (Roche, 1:1,000); mouse Myc (Santa Cruz Biotechnology, 1:500); human linear ubiquitin (Genentech, 1:1,000) and rabbit pan-ubiquitin (Dako, 1:1,000) Immunoprecipitation. Human HEK293T cells were transfected using Effectene transfection reagent (Qiagen). Cells were lysed 18-24 h after transfection in 50 mM Tris pH 7.4, 100 mM EDTA, 150 mM NaCl and 0.5% Triton X-100 and protease inhibitor cocktail (Roche). Aliquots containing 400 mg total protein were incubated for 1 h with 1 mg Flag antibody (Mouse M2, Sigma), 2 mg Myc antibody (mouse, Santa Cruz) or 2 mg HA antibody (rat, high affinity, Roche). 20 ml of Protein A/G plus agarose beads (Santa Cruz) were added and co-immunoprecipitation was performed as in ref. 42 . For DVL2 immunoprecipitation, 4 mM MG132 was also added to media 18 h after transfection and during lysis and immunoprecipitation. Samples were analysed by immunoblot. In vitro luciferase assays. Wnt signalling was assayed in HEK293T cells cotransfected with various expression constructs and with TOPFLASH or FOPFLASH reporters 43 and the normalizing transfection efficiency control PRL vector using Effectene (Qiagen), incubated for 18-20 h and then stimulated for 4 h with WNT3A conditioned or control media. Similarly, NF-kB-dependent transcription was assayed with a reporter containing six NF-kB binding sites and a control plasmid with six AP1 binding sites that drive firefly luciferase expression in Dual luciferase assays (Promega) 15 . Values were normalized relative to Flag-pcDNA3.1. Constructs did not activate the FOPFLASH or AP1 reporters. At least three independent experiments were performed with samples in triplicate for each construct.
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Analysis of linear ubiquitinated proteins. Analyses of linear ubiquitinated proteins by immunoblot and immunofluorescence were performed as described previously 26 . For embryonic lysates, embryos were collected at E10.5 and washed twice with PBS. Individual embryos and 293T cells were lysed in 8 M urea, 50 mM Tris pH 7.5, 25 mM NaCl, 2 mM EDTA, 2 mM N-ethylmaleimide and complete mini protease inhibitors (Roche) and were disrupted by passing through an 18 gauge needle. Protein expression and purification. Human FAM105B residues 79-352 (gumby R79 ) corresponding to the catalytic domain and residues 55-352 (gumby M55 ) corresponding to the catalytic domain with an additional 24-residue N-terminal extension, were amplified by PCR from a full-length cDNA clone (IMAGE: 4430188) and cloned into pGEX-TEV downstream of GST and pProEx-TEV downstream of His 6 . W96R, C129A, C129S and D336E mutations were introduced using standard techniques and all clones were sequence verified. Linear diubiquitin was generated by PCR amplification of residues 1-152 from Ubc (IMAGE:4076286) and cloned into pProEx.
Native and selenomethionine-labelled His 6 -tagged gumby proteins, ubiquitin and linear di-ubiquitin were expressed in Escherichia coli BL21(DE3) Codon1 (Agilent Technologies) and purified using a HiTrap nickel chelating HP column (GE Healthcare) using standard laboratory protocols. Tag-free proteins in 20 mM HEPES pH 7.5, 100 mM NaCl, 5 mM b-mercaptoethanol were concentrated to 10-25 mg ml 21 and stored frozen at 280 uC.
5-Iodoacetamidofluorescein (5-IAF, Molecular Probes)-labelled linear diubiquitin was generated by incubating 100 mM purified diUb Cys0 (modified by inclusion of a non-native cysteine residue at the ubiquitin amino terminus) with 500 mM of 5-IAF in a buffer containing 20 mM HEPES pH 7.5, 100 mM NaCl, and 1 mM dithiothreitol (DTT) for 3 h at 20 uC followed by size exclusion chromatography.
Purified USP2, USP5 and USP21 were obtained as described previously 44 . Structure determination by X-ray crystallography. Crystals of gumby R79 were grown at 20 uC by mixing equal volumes of 600 mM protein with solution containing 100 mM MES pH 6.0, 200 mM MgCl 2 , 19% PEG3350 and cryo-protected with 20% glycerol. Diffraction to 1.60 Å resolution (l 5 0.97917) was collected at NE-CAT 24-ID-C beamline at 100K and processed using HKL2000. Phased electron density maps from nine seleno-methionine positions were generated by SHELX. Protein structure was built using Arp/Warp and refined using Phenix and Coot. 96.4%, 3.6% and 0% of the residues resided in the most favoured, allowed and disallowed regions of the Ramachandran plot, respectively (Procheck). Crystals of an equimolar mixture of gumby M55-C129S and ubiquitin (900 mM final concentration) were grown at 20 uC by mixing equal volumes of protein with solution containing 100 mM Bis Tris pH 5.5, 200 mM ammonium sulphate, 20% PEG3350 and cryo-protected with 20% glycerol. Diffraction data was collected at 100K at a home source (l 5 1.5418) with Rigaku Saturn9441 detector and processed using HKL3000. Crystals of an equimolar complex of gumby R79-C129A and linear diubiquitin were grown at 20 uC by mixing equal volumes of protein with a solution of 100 mM acetate pH 5.5, 100 mM CaCl 2 , 100 mM glycine, 2.5 M sodium formate and 24% PEG 3350 and cryoprotected with Paratone-N. Diffraction data was collected at NE-CAT 24-ID-C beam line (l 5 0.97917) at 100K and processed using HKL2000. The gumby-ubiquitin and gumby-linear diubiquitin co-structures were determined by molecular replacement using Phaser with gumby R79 and ubiquitin as search models. 94.8%, 4.7% and 0.5% of residues in the gumby-ubiquitin complex and 96.8%, 2.4% and 0.8% of residues in the gumby-diubiquitin complex reside in most favoured, allowed and disallowed regions, respectively. Statistics for data collection, phasing and structure refinement are presented in Supplementary  Table 1 . Deubiquitination assay. Substrate specificity analysis of gumby and OTUB1 shown in Fig. 3b was determined by incubating 1 mg of the indicated diubiquitin substrates (Boston Biochem) with 1 mg of the indicated DUB in a 20 ml reaction with 20 mM HEPES pH 7.5, 300 mM NaCl, 1 mM DTT at 37 uC for 18 h. Reactions were stopped by the addition of 63 Laemmli buffer. Reaction products were subjected to 4-12% PAGE and stained with Coomassie brilliant blue.
For enzyme titration experiments in Supplementary Fig. 8a and e, 1 mg of linear diubiquitin or K48-linked diubiquitin was incubated with the indicated concentration of gumby or OTUB1 in 20 mM HEPES pH 7.5, 300 mM NaCl, 1 mM DTT at 37 uC for 30 min in a 10-ml volume. Reactions were stopped by the addition of 63 Laemmli buffer, subjected to 15% PAGE and gel stained with Coomassie brilliant blue.
Kinetic analyses of gumby M55 , gumby R79 , gumby D336E and gumby W96R DUB activity were performed by determining the initial reaction rates from a series of diubiquitin cleavage reactions containing 0.08 to 150 mM of fluorescein-labelled linear diubiquitin substrate. Reactions were performed at 37 uC in 20 mM HEPES pH 7.5, 300 mM NaCl, 1 mM DTT by mixing gumby (0.5 nM gumby M55 , 0.4 nM gumby R79 , 30 nM gumby D336E or 25 mM gumby W96R ) and fluorescein-labelled linear diubiquitin at 0.08, 0.4, 2, 10, 25, 50, 100 or 150 mM concentration. 35 ml aliquots were obtained at various time points from a 600 ml reaction volume, stopped by the addition of 63 Laemmli buffer, and followed by 15% PAGE analysis. The gel was imaged with a Typhoon FLA 9500 (GE Healthcare) using the Alexa-Fluor 488nM protocol. Bands on the gel corresponding to fluoresceinlabelled monoubiquitin and standards of fluorescein-labelled diubiquitin were used to quantify the amount of reaction product at each time point using ImageQuant (GE Healthcare). Initial rates for each reaction performed in duplicate were calculated from the linear portions of each reaction profile and fitted to a nonlinear Michaelis-Menten equation using Prism v5 (GraphPad Software Inc.) to calculate K m , V max and k cat values. (See Supplementary Microsoft Excel spreadsheet for replicate data.)
For ubiquitin-vinyl sulphone inhibition assays shown in Supplementary Fig. 8b , 0.6 mM gumby, USP2, USP5 and USP21 were incubated with indicated amounts of ubiquitin-vinyl sulphone (Boston Biochem) for 30 min at 37 uC and subsequently used in a DUB assay as described above. Ub-AMC assays shown in Supplementary  Fig. 8c were carried out with 5, 50 and 500 nM of the indicated DUBs and 600 nM of Ub-AMC (Boston Biochem) in a buffer containing 50 mM HEPES pH 7.5, 100 mM NaCl, 0.03% Brij-35, and 0.1 mg ml 21 BSA for 2 h at 30 uC. Fluorescence was measured using an EnSpire 2300 plate reader (PerkinElmer) at 380 nm excitation and 480 nm emission wavelengths. Isothermal titration calorimetry. Calorimetric titrations were carried out on a Microcal VP-ITC titration calorimeter. Protein samples were prepared in 20 mM HEPES, pH 7.5, 300 mM NaCl, 1 mM DTT. 0.2-0.5 mM linear diubiquitin within the syringe was titrated into 20-50 mM concentrations of gumby C129S or gumby C129S/W96R proteins residing in the sample cell. Experiments were carried out minimally in triplicate at 30 6C. Data analysis was performed using Origin software (Microcal) (See Supplementary Microsoft Excel spreadsheet for replicate data). Mass spectrometric analysis. For mass spectrometry, generation of stable inducible cell lines, induction of protein expression and affinity purification on Flag M2 magnetic beads was performed as described 45 . Proteins digested with trypsin on beads were loaded onto reversed-phase capillary columns and analysed by LC-MS/MS on a LTQ mass spectrometer, as described previously 46 . RAW files were saved in our local interaction proteomics LIMS, ProHits 47 , searched with Mascot version 2.3 (Matrix Science) against the human and adenovirus complements of the RefSeq protein database (version 45; 34604 entries), enabling one missed cleavage site, and Met oxidation and Asn/Gln deamidation as variable modifications. Search results were further analysed within ProHits 45 using the SAINT statistical tool 48, 49 . SAINT analysis was done using two biological replicates per bait. Bait protein samples were analysed alongside 8 negative control runs (Flag alone), using the following parameters: 8 negative controls compressed into 6 (nControl:6); nburn: 2000, niter: 5000, lowMode: 0; minFold: 1, normalize: 1 (ref. 48) . After SAINT analysis, results were further filtered to show only those proteins identified in with an average SAINT probability of 0.9, at least 2 unique peptides, and with a frequency of identification less than in 10% of all the samples annotated in a database consisting of .2,000 Flag AP-MS experiments.
